Facio announces completion of real-world data study in FSHD

Tuesday, October 15, 2019

Facio Therapies announced the completion of an exploratory study to evaluate the utility of real-world data for monitoring the progression of FSHD and the impact of FSHD on daily life. This study, which was conducted by the Centre for Human Drug Research (Leiden), represents the very first effort in the FSHD field to ultimately discover clinical outcome measures based on real-world patient data obtained with the use of digital technologies.

Read more

Biotech Training Facility: unique professional GMP and biosafety courses in a state-of-the-art environment.

BTF